Topical ruxolitinib cream shows promise as a treatment for inflammatory skin conditions, but lacks consistent data, indicating a need for further research into its use across various dermatologic ...

Endangered mountain caribou in British Columbia possess a unique gut microbiome in late winter when they feed on tree lichens ...

Dr. Jonathan Kaufman, Chief Executive Officer and Co-Founder of Lipella, said, "We are pleased to renew our collaboration ...

"These findings support LP-310's potential as a localized, non-steroidal treatment for Oral Lichen Planus. We look forward to sharing final topline data from the fully enrolled trial in the second ...

The abstract, titled "Liposomal Tacrolimus (LP-10) Oral Rinse for the Treatment of Oral Lichen Planus: Topline Analysis of a Phase 2a Multicenter Dose-Ranging Trial," presents data from an ongoing ...

Oral Lichen Planus Symptom Severity Measure (OLPSSM): Decreased from 14.92 ± 2.10 at baseline to 9.87 ± 2.27 at week 1 (p=0.032), 4.88 ± 2.15 at week 4 (p=0.003) and 8.42 ± 3.98 at week 6 (p=0 ...

What Is Oral Lichen Planus? Oral lichen planus is a long-lasting disease that affects your mouth, causing symptoms such as painful white patches, redness, and swelling. It doesn't go away ...

Low-level light therapy (LLLT) may be a more effective treatment for oral lichen planus (OLP) than topical corticosteroids, according to a review study recently published in the Journal of ...

This rise, notable post-Covid, may stem from immune reactions, allergies, medications, chemicals or illnesses Health professionals have been noticing a rise in cases of Lichen Planus, a chronic ...

Lichen planus affects 1 to 2% of the general population, altering the quality of life for patients due to intense itching or pain. On the skin, lichen planus often appears as purple, itchy, flat ...

Research suggests people with the hepatitis C virus (HCV) may be more likely to develop lichen planus, while those with lichen planus may be more likely to test positive for HCV. Lichen planus is ...

Titled “Rationale for the Use of Topical Calcineurin Inhibitors in the Management of Oral Lichen Planus and Mucosal Inflammatory Diseases,” the paper focuses on non-steroid treatments for oral ...